115 related articles for article (PubMed ID: 9139857)
1. Expression and immunogenicity in rats of recombinant adenovirus 5 DNA plasmids and vaccinia virus containing the HTLV-I env gene.
Kazanji M; Bomford R; Bessereau JL; Schulz T; de Thé G
Int J Cancer; 1997 Apr; 71(2):300-7. PubMed ID: 9139857
[TBL] [Abstract][Full Text] [Related]
2. Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene.
Ibuki K; Funahashi SI; Yamamoto H; Nakamura M; Igarashi T; Miura T; Ido E; Hayami M; Shida H
J Gen Virol; 1997 Jan; 78 ( Pt 1)():147-52. PubMed ID: 9010298
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I.
Hakoda E; Machida H; Tanaka Y; Morishita N; Sawada T; Shida H; Hoshino H; Miyoshi I
Int J Cancer; 1995 Feb; 60(4):567-70. PubMed ID: 7829272
[TBL] [Abstract][Full Text] [Related]
4. Expression and immunogenicity of the entire human T cell leukaemia virus type I envelope protein produced in a baculovirus system.
Arp J; Ford CM; Palker TJ; King EE; Dekaban GA
J Gen Virol; 1993 Feb; 74 ( Pt 2)():211-22. PubMed ID: 8429302
[TBL] [Abstract][Full Text] [Related]
5. A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.
Arp J; LeVatte M; Rowe J; Perkins S; King E; Leystra-Lantz C; Foung SK; Dekaban GA
J Virol; 1996 Nov; 70(11):7349-59. PubMed ID: 8892853
[TBL] [Abstract][Full Text] [Related]
6. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
[TBL] [Abstract][Full Text] [Related]
7. Antibody reactivity to different regions of human T-cell leukemia virus type 1 gp61 in infected people.
Chen YM; Lee TH; Samuel KP; Okayama A; Tachibana N; Miyoshi I; Papas TS; Essex M
J Virol; 1989 Nov; 63(11):4952-7. PubMed ID: 2677406
[TBL] [Abstract][Full Text] [Related]
8. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of human T cell leukemia virus type-I (HTLV-I) antigens for cytotoxic T lymphocytes in the rat system.
Tanaka Y; Isobe A; Masuda M; Tozawa H; Koyanagi Y; Yamamoto N; Shida H
J Immunol; 1991 Nov; 147(10):3646-52. PubMed ID: 1940363
[TBL] [Abstract][Full Text] [Related]
10. Envelope proteins of human T-cell leukemia virus: expression in Escherichia coli and its application to studies of env gene functions.
Kiyokawa T; Yoshikura H; Hattori S; Seiki M; Yoshida M
Proc Natl Acad Sci U S A; 1984 Oct; 81(19):6202-6. PubMed ID: 6091139
[TBL] [Abstract][Full Text] [Related]
11. Induction of neutralizing antibodies against HTLV-I envelope proteins after combined genetic and protein immunizations in mice.
Grange MP; Armand MA; Audoly G; Thollot D; Desgranges C
DNA Cell Biol; 1997 Dec; 16(12):1439-48. PubMed ID: 9428792
[TBL] [Abstract][Full Text] [Related]
12. Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells.
Tanaka Y; Tozawa H; Koyanagi Y; Shida H
J Immunol; 1990 Jun; 144(11):4202-11. PubMed ID: 2187927
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).
Kazanji M; Tartaglia J; Franchini G; de Thoisy B; Talarmin A; Contamin H; Gessain A; de Thé G
J Virol; 2001 Jul; 75(13):5939-48. PubMed ID: 11390595
[TBL] [Abstract][Full Text] [Related]
14. Preparation of a murine cell line which stably expresses human T lymphotropic virus type I (HTLV-I) env genome products.
Joh T; Fujita M; Tanaka Y; Shiku H
Gene; 1995 Aug; 161(2):227-30. PubMed ID: 7665084
[TBL] [Abstract][Full Text] [Related]
15. Infection of rats with human T-cell leukemia virus type-I: susceptibility of inbred strains, antibody response and provirus location.
Ibrahim F; Fiette L; Gessain A; Buisson N; de-Thé G; Bomford R
Int J Cancer; 1994 Aug; 58(3):446-51. PubMed ID: 8050826
[TBL] [Abstract][Full Text] [Related]
16. Targeted expression of HTLV-I envelope proteins in muscle by DNA immunization of mice.
Armand MA; Grange MP; Paulin D; Desgranges C
Vaccine; 2000 Apr; 18(21):2212-22. PubMed ID: 10717340
[TBL] [Abstract][Full Text] [Related]
17. Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.
Tanaka Y; Tanaka R; Terada E; Koyanagi Y; Miyano-Kurosaki N; Yamamoto N; Baba E; Nakamura M; Shida H
J Virol; 1994 Oct; 68(10):6323-31. PubMed ID: 8083972
[TBL] [Abstract][Full Text] [Related]
18. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.
Earl PL; Moss B; Morrison RP; Wehrly K; Nishio J; Chesebro B
Science; 1986 Nov; 234(4777):728-31. PubMed ID: 3490689
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).
Tanaka Y; Yasumoto M; Nyunoya H; Ogura T; Kikuchi M; Shimotohno K; Shiraki H; Kuroda N; Shida H; Tozawa H
Int J Cancer; 1990 Oct; 46(4):675-81. PubMed ID: 1698731
[TBL] [Abstract][Full Text] [Related]
20. Detection of neutralizing antibodies against human T-cell leukemia virus type 1 using a cell-free infection system and polymerase chain reaction.
Haraguchi Y; Yang DW; Handa A; Shimizu N; Tanaka Y; Hoshino H
Int J Cancer; 1994 Nov; 59(3):416-21. PubMed ID: 7927951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
